VPML

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023

GOTHENBURG, Sweden, April 16, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2023 are now available, in Swedish, on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. For further information, please contactIsofol Medical […]

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023 Read More »

Isofol Medical AB (publ) publishes interim report, January–June 2023

GOTHENBURG, Sweden, August 22, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s interim report for January–June 2023 is now available on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. Second quarter, April–June 2023 Net revenue amounted to TSEK 0 (4,027) and other revenue

Isofol Medical AB (publ) publishes interim report, January–June 2023 Read More »

Isofol Medical AB (publ) publishes interim report, January–June 2022

GOTHENBURG, Sweden, August 23, 2022 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s interim report for January–June 2022 is now available on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. Second quarter, April–June 2022 Net revenue amounted to TSEK 4,027 (7,333) and other revenue

Isofol Medical AB (publ) publishes interim report, January–June 2022 Read More »

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2021

GOTHENBURG, Sweden, April 27, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2021 are now available on the company’s website, www.isofolmedical.com (https://isofolmedical.com/investors/financial-reports/). For further information, please contact Isofol Medical AB (publ) Jarl Ulf Jungnelius, M.D., Chief Executive Officer   E-mail: jungnelius@isofolmedical.com  

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2021 Read More »

Scroll to Top